(Q38548196)

4 September 2017

1 reference

title

Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis (English)

1 reference

systemic lupus erythematosus

4 September 2017

1 reference

1 reference

Angulo JM

1

1 reference

PubMed ID

9872479

4 September 2017

Sigal LH

series ordinal

2

1 reference

PubMed ID

9872479

4 September 2017

Espinoza LR

series ordinal

3

1 reference

4 September 2017

1 December 1998

1 reference

Seminars in Arthritis and Rheumatism

4 September 2017

1 reference

4 September 2017

28

1 reference

4 September 2017

3

1 reference

4 September 2017

187-192

1 reference

Pharmacokinetic studies on minocycline in man.

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Unique metabolic fate of a tetracycline (minocycline)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Serum sickness-like syndrome associated with minocycline therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline-related lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline-related lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Lupus-like syndrome associated with the use of minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline-related lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Lupuslike reaction associated with minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Acute hepatitis and exfoliative dermatitis associated with minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Study of immune reactivity of minocycline-induced chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

1 reference

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Validation of scoring system for diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980035-8

7 January 2021

10.1016/S0049-0172(98)80035-8

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

9872479